Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
THRX > SEC Filings for THRX > Form 8-K on 24-Mar-2014All Recent SEC Filings

Show all filings for THERAVANCE INC

Form 8-K for THERAVANCE INC


24-Mar-2014

Regulation FD Disclosure


Item 7.01 Regulation FD Disclosure.

The information contained in this Item 7.01 shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Securities Exchange Act of 1934"), or incorporated by reference in any filing under the Securities Exchange Act of 1934 or the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

GlaxoSmithKline plc (GSK) is scheduled to present data from a Phase 3 study, "Efficacy and Safety of Once-Daily Fluticasone Furoate/Vilanterol (FF/VI) and FF Over 12 Weeks In Patients With Persistent Asthma," and the protocol of the Phase 3 Salford Lung Study of FF/VI in asthma at the American Thoracic Society (ATS) 2014 International Conference held in San Diego, California from May 16-21, 2014. In addition, GSK is scheduled to present data from a Phase 1 concentration QT analysis study and post-hoc data analyses from Phase 3 studies of umeclidinium/vilanterol (UMEC/VI). BREO® ELLIPTA® is the proprietary name in the United States (U.S.) and Canada for FF/VI. RELVAR® ELLIPTA® is the proprietary name for FF/VI outside of the U.S. and Canada. RELVAR®/BREO® ELLIPTA® is a combination of the inhaled corticosteroid, FF, and the long-acting beta2-agonist (LABA), VI, in a single inhaler. ANORO™ ELLIPTA™ is the proprietary name for UMEC/VI. ANORO™ ELLIPTA™ is a combination of two bronchodilators, a LABA and an anticholinergic in a single inhaler. UMEC/VI and FF/VI have been developed under the 2002 LABA collaboration between GSK and Theravance, Inc. Titles and abstracts of poster presentations can be found in the Program Itinerary section of the ATS 2014 conference website
https://cms.psav.com/cPaper2014/ats2014/myitinerary.


  Add THRX to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for THRX - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.